Skip To Main Content
Guanying Yu on Muck Rack

Guanying Yu

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Guanying

Contact Guanying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Frontiers | Case Report: Biweekly TAS-102 and bevacizumab as maintenance therapy for recurrent and metastatic pseudomyxoma peritonei following palliative cytoreduction

|
By Baoxuan Wang, Yan Wang, Dong Zhao, Houjun Zhang, Qi Liu, Jie Jiao, Guanying Yu
| Frontiers
Introduction Pseudomyxoma peritonei (PMP) is a rare disease with a reported annual incidence of approximately 1–3 cases per million (1). Cytoreductive surgery (CRS) combined with peritoneal hyperthermic intraperitoneal chemotherapy (HIPEC) is considered to be an effective treatment to improve disease control and enhance long-term survival (2).
Open in Who Shared Issue with article?
See all 1 articles